000 | 01816 a2200505 4500 | ||
---|---|---|---|
005 | 20250518033904.0 | ||
264 | 0 | _c20200310 | |
008 | 202003s 0 0 eng d | ||
022 | _a1748-605X | ||
024 | 7 |
_a10.1088/1748-605X/ab1a04 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKimna, Ceren | |
245 | 0 | 0 |
_aChitosan/montmorillonite composite nanospheres for sustained antibiotic delivery at post-implantation bone infection treatment. _h[electronic resource] |
260 |
_bBiomedical materials (Bristol, England) _c05 2019 |
||
300 |
_a044101 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a3T3 Cells |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aBentonite _xchemistry |
650 | 0 | 4 |
_aBone Transplantation _xadverse effects |
650 | 0 | 4 |
_aBone and Bones _xmicrobiology |
650 | 0 | 4 |
_aChitosan _xchemistry |
650 | 0 | 4 | _aDiffusion |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aEscherichia coli |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aGentamicins _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNanocomposites _xchemistry |
650 | 0 | 4 |
_aOsteoblasts _xdrug effects |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 |
_aProsthesis-Related Infections _xdrug therapy |
650 | 0 | 4 | _aStaphylococcus aureus |
650 | 0 | 4 |
_aVancomycin _xadministration & dosage |
650 | 0 | 4 | _aX-Ray Diffraction |
700 | 1 | _aDeger, Sibel | |
700 | 1 | _aTamburaci, Sedef | |
700 | 1 | _aTihminlioglu, Funda | |
773 | 0 |
_tBiomedical materials (Bristol, England) _gvol. 14 _gno. 4 _gp. 044101 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1088/1748-605X/ab1a04 _zAvailable from publisher's website |
999 |
_c29594823 _d29594823 |